1. Home
  2. CTRI vs NRIX Comparison

CTRI vs NRIX Comparison

Compare CTRI & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTRI
  • NRIX
  • Stock Information
  • Founded
  • CTRI 1909
  • NRIX 2009
  • Country
  • CTRI United States
  • NRIX United States
  • Employees
  • CTRI N/A
  • NRIX N/A
  • Industry
  • CTRI
  • NRIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CTRI
  • NRIX Health Care
  • Exchange
  • CTRI Nasdaq
  • NRIX Nasdaq
  • Market Cap
  • CTRI 1.8B
  • NRIX 1.7B
  • IPO Year
  • CTRI 2024
  • NRIX 2020
  • Fundamental
  • Price
  • CTRI $22.39
  • NRIX $17.58
  • Analyst Decision
  • CTRI Hold
  • NRIX Strong Buy
  • Analyst Count
  • CTRI 4
  • NRIX 14
  • Target Price
  • CTRI $23.25
  • NRIX $26.50
  • AVG Volume (30 Days)
  • CTRI 2.2M
  • NRIX 1.5M
  • Earning Date
  • CTRI 11-05-2025
  • NRIX 10-09-2025
  • Dividend Yield
  • CTRI N/A
  • NRIX N/A
  • EPS Growth
  • CTRI N/A
  • NRIX N/A
  • EPS
  • CTRI 0.03
  • NRIX N/A
  • Revenue
  • CTRI $2,841,255,000.00
  • NRIX $83,687,000.00
  • Revenue This Year
  • CTRI $6.70
  • NRIX $58.48
  • Revenue Next Year
  • CTRI $5.58
  • NRIX N/A
  • P/E Ratio
  • CTRI $788.61
  • NRIX N/A
  • Revenue Growth
  • CTRI 9.89
  • NRIX 48.32
  • 52 Week Low
  • CTRI $14.46
  • NRIX $8.18
  • 52 Week High
  • CTRI $24.60
  • NRIX $23.00
  • Technical
  • Relative Strength Index (RSI)
  • CTRI 61.94
  • NRIX 80.91
  • Support Level
  • CTRI $19.04
  • NRIX $16.63
  • Resistance Level
  • CTRI $20.76
  • NRIX $17.65
  • Average True Range (ATR)
  • CTRI 0.93
  • NRIX 0.99
  • MACD
  • CTRI 0.15
  • NRIX 0.41
  • Stochastic Oscillator
  • CTRI 97.38
  • NRIX 98.52

About CTRI Centuri Holdings Inc. Common Stock

Centuri Holdings Inc is a pure-play North American utility infrastructure services company that partners with regulated utilities to maintain, upgrade and expand the energy network that powers millions of homes and businesses. Its service offerings consist of the modernization of utility infrastructure through the maintenance, retrofitting and installation of electric and natural gas distribution networks to meet current and future demands while also preparing systems for the transition to clean energy sources. It operates under two primary lines of business which includes Gas Utility Services and Electric Utility Services it is also their two reportable segments as well.

About NRIX Nurix Therapeutics Inc. Common stock

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.

Share on Social Networks: